These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11705686)

  • 21. [Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulins].
    Szép Z; Danilla T; Buchvald D
    Cas Lek Cesk; 2005; 144(10):700-3. PubMed ID: 16279438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris.
    Thakur BK; Bernardi DM; Murali MR; McClain SA; Clark RA
    J Am Acad Dermatol; 1998 Mar; 38(3):488-90. PubMed ID: 9520034
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
    Esmaili N; Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Toosi S; Karimi A; Mortazavi H
    Arch Iran Med; 2014 Sep; 17(9):626-8. PubMed ID: 25204479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness and safety of rituximab in pemphigus vulgaris].
    Alonso Sánchez A; García Rodríguez S; López Avila A; Rabell Iñigo S
    Farm Hosp; 2010; 34(2):98-9. PubMed ID: 20304370
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjuvant therapy of pemphigus.
    Bystryn JC
    Arch Dermatol; 1984 Jul; 120(7):941-51. PubMed ID: 6375579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The actual management of pemphigus.
    Daniel BS; Murrell DF
    G Ital Dermatol Venereol; 2010 Oct; 145(5):689-702. PubMed ID: 20930702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of pemphigus].
    van Beek N; Zillikens D; Schmidt E
    Hautarzt; 2019 Apr; 70(4):243-253. PubMed ID: 30887081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial and the treatment of pemphigus vulgaris.
    Margolis DJ
    J Invest Dermatol; 2010 Aug; 130(8):1964-6. PubMed ID: 20631749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.
    Kasperkiewicz M; Shimanovich I; Meier M; Schumacher N; Westermann L; Kramer J; Zillikens D; Schmidt E
    Br J Dermatol; 2012 Jan; 166(1):154-60. PubMed ID: 21910700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pemphigus: a review].
    Joly P; Sin C
    Ann Dermatol Venereol; 2011 Mar; 138(3):182-200. PubMed ID: 21397148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pemphigus vulgaris--still a difficult disease to treat.
    Menezes N; Leite I; Tente D; Couceiro A; Baptista A; Varela P
    Int J Dermatol; 2010 Feb; 49(2):230-2. PubMed ID: 20465654
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunosuppressive therapy for autoimmune bullous diseases.
    Meurer M
    Clin Dermatol; 2012; 30(1):78-83. PubMed ID: 22137230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New and innovative interventions in the management of pemphigus.
    Frydman AS; Fairley JA
    G Ital Dermatol Venereol; 2011 Jun; 146(3):211-24. PubMed ID: 21566551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of idiopathic membranous nephropathy].
    Passerini P
    G Ital Nefrol; 2004; 21(6):531-9. PubMed ID: 15593020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine.
    Fine JD; Appell ML; Green LK; Sams WM
    Arch Dermatol; 1988 Feb; 124(2):236-9. PubMed ID: 3277542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep venous thrombosis after high-dose intravenous immunoglobulin in the treatment of pemphigus vulgaris.
    Sheehan DJ; Lesher JL
    Cutis; 2004 Jun; 73(6):403-6. PubMed ID: 15224785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
    Takeda Y; Tomino Y
    Nihon Rinsho; 2004 Oct; 62(10):1875-9. PubMed ID: 15500133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.